Access Bio, Inc. (950130.KQ)
KRW 5370.0
(-2.54%)
KRW 5370.0
(-2.54%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 348.64 Billion | 1033.86 Billion | 505.11 Billion | 121.79 Billion | 43.05 Billion | 40.23 Billion |
| Cost of Revenue | 178.38 Billion | 214.09 Billion | 108.72 Billion | 31.05 Billion | 33.65 Billion | 24.64 Billion |
| Gross Profit | 170.26 Billion | 819.76 Billion | 396.38 Billion | 90.74 Billion | 9.4 Billion | 15.59 Billion |
| Operating Expenses | 148.67 Billion | 350.16 Billion | 136.26 Billion | 22.04 Billion | 17.44 Billion | 20.97 Billion |
| Selling, General and Administrative Expenses | 170.63 Billion | 317.4 Billion | 45.2 Billion | 6.9 Billion | 6.88 Billion | 7.78 Billion |
| Research and Development Expenses | 16.08 Billion | 7.31 Billion | 4.89 Billion | 4 Billion | 2.19 Billion | 2.93 Billion |
| Other Expenses | -38.04 Billion | 25.43 Billion | 86.16 Billion | 11.13 Billion | 8.36 Billion | -283.68 Million |
| Cost and Expenses | 327.05 Billion | 564.25 Billion | 244.98 Billion | 53.09 Billion | 51.09 Billion | 45.62 Billion |
| Operating Income | 21.59 Billion | 469.2 Billion | 260.12 Billion | 68.7 Billion | -8.03 Billion | -4.38 Billion |
| Interest Expense | 3.71 Billion | 6.23 Billion | 3.34 Billion | 1.86 Billion | 2.19 Billion | 1.81 Billion |
| Income Tax Expense | -580.47 Million | 113.95 Billion | 66.68 Billion | 14.66 Billion | -955.34 Million | 243.84 Million |
| Earnings before Tax | -5.87 Billion | 463.69 Billion | 256.76 Billion | 62.47 Billion | -21.61 Billion | -6.14 Billion |
| Net Income | -3.17 Billion | 346.67 Billion | 189.68 Billion | 48.27 Billion | -20.65 Billion | -4.24 Billion |
| Earnings Per Share Basic | -91.00 | 10.05 Thousand | 5333.00 | 1428.00 | -725.82 | -165.00 |
| Earnings Per Share Diluted | -91.00 | 9212.00 | 5127.00 | 1392.00 | -725.82 | -165.00 |
| Weighted Average Shares Outstanding | 34.86 Million | 37.63 Million | 35.56 Million | 33.8 Million | 28.45 Million | 25.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 34.86 Million | 37.63 Million | 36.99 Million | 34.67 Million | 28.45 Million | 25.7 Million |
| Gross Margin | 0.49 | 0.79 | 0.78 | 0.75 | 0.22 | 0.39 |
| EBIT Margin | 0.04 | 0.47 | 0.52 | 0.60 | -0.09 | -0.04 |
| Profit Margin | -0.01 | 0.34 | 0.38 | 0.40 | -0.48 | -0.11 |
| EBITDA | 13.79 Billion | 480.75 Billion | 266.17 Billion | 72.92 Billion | -3.82 Billion | -1.25 Billion |
| Earnings Before Tax Margin | 0.06 | 0.45 | 0.51 | 0.56 | -0.19 | -0.11 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 25.08 Billion | 35.1 Billion | 348.64 Billion | 36.25 Billion | 3.05 Billion | 65.03 Billion |
| Cost of Revenue | 12.7 Billion | 17.18 Billion | 178.38 Billion | 39.81 Billion | 10.84 Billion | 28.53 Billion |
| Gross Profit | 12.38 Billion | 17.92 Billion | 170.26 Billion | -3.56 Billion | -7.79 Billion | 36.5 Billion |
| Operating Expenses | 14.99 Billion | 15.7 Billion | 148.34 Billion | 10.98 Billion | 12.21 Billion | 35.21 Billion |
| Selling, General and Administrative Expenses | 6.32 Billion | 7.57 Billion | - | 10.95 Billion | 4.27 Billion | 26.46 Billion |
| Research and Development Expenses | 4.32 Billion | 2.22 Billion | - | 1.84 Billion | 3.17 Billion | 6.96 Billion |
| Other Expenses | 38.32 Million | -69.43 Million | -36.31 Billion | -33.58 Million | 98.15 Million | -36.3 Billion |
| Cost and Expenses | 27.69 Billion | 32.89 Billion | 326.72 Billion | 50.8 Billion | 23.06 Billion | 63.74 Billion |
| Operating Income | -2.6 Billion | 2.16 Billion | 21.59 Billion | -14.64 Billion | -20.09 Billion | 1.21 Billion |
| Interest Expense | 890.13 Million | 902.85 Million | 3.71 Billion | 918.42 Million | 904.32 Million | 927.18 Million |
| Income Tax Expense | 258.11 Million | 1.62 Billion | -580.47 Million | -2.24 Billion | -7.36 Billion | -7.24 Billion |
| Earnings before Tax | 1.6 Billion | 4.22 Billion | -5.87 Billion | -16 Billion | -14.99 Billion | -32.32 Billion |
| Net Income | 1.52 Billion | 2.71 Billion | -3.17 Billion | -12.85 Billion | -7.14 Billion | -25.03 Billion |
| Earnings Per Share Basic | 40.00 | 80.00 | - | -371.41 | -208.00 | -738.00 |
| Earnings Per Share Diluted | 40.00 | 80.00 | - | -371.41 | -208.00 | -738.00 |
| Weighted Average Shares Outstanding | 38.18 Million | 33.91 Million | 34.86 Million | 34.61 Million | 34.36 Million | 33.92 Million |
| Weighted Average Shares Outstanding (Diluted) | 38.18 Million | 33.91 Million | 34.86 Million | 34.61 Million | 34.36 Million | 33.92 Million |
| Gross Margin | 0.49 | 0.51 | 0.49 | -0.10 | -2.55 | 0.56 |
| EBIT Margin | 0.20 | 0.29 | - | -0.19 | -3.90 | -0.43 |
| Profit Margin | 0.06 | 0.08 | -0.01 | -0.35 | -2.34 | -0.38 |
| EBITDA | 5 Billion | 10.04 Billion | - | -7 Billion | -11.9 Billion | -27.82 Billion |
| Earnings Before Tax Margin | -0.10 | 0.06 | 0.06 | -0.40 | -6.59 | 0.02 |
000426
LXMIATO
SRHHYPOLTD
WACLY
002140
ELPE